C4U株式会社

C4U株式会社

Revolutionizing our lives with

CRISPR CRISPR -Cas3

a novel genome-editing technology

Our science

Aiming for safer,
more accessible
genome editing technology

Breeding, or "crossbreeding," has been practiced since ancient times, but the discovery of "genome editing technology," especially the CRISPR-Cas9 system discovered in 2012, has brought revolutionary technological innovation due to its simplicity and speed.

With the Nobel Prize in Chemistry to be awarded in 2020 and the approval of a new gene therapy utilizing Cas9 technology in 2023, expectations for genome editing technology are rising.

Under these circumstances, CRISPR-Cas3, invented by Professor Tomoji Mashimo and his group, is a novel technology from Japan that opens up new possibilities for genome editing by making it safer and more widely applicable.

Our Business

Creating a Sustainable
Society by Implementing
CRISPR-Cas3 in the industry

Based on cutting-edge research,
CRISPR-Cas3 is being applied as a platform technology not only for medical applications,
but also for a wide range of industrial applications.

Careers

We welcome people who are interested in "developing new therapeutic technologies for intractable diseases" and "developing new technologies to solve societal problems" using genome editing technology, as well as people with a spirit of curiosity and a high level of challenge.